Table 3 –

Incidence and cumulative risk of kidney cancer in Asia

Population	Quality^a	Numbers	Crude rate	ASR (W)	Cumulative risk
Israel	A2	1002	13.0	10.0	1.17
Korea, Republic of	A2	5651	11.6	8.0	0.91
Turkey	C6	3992	5.4	5.6	0.62
Japan	B1	16 830	13.3	5.3	0.59
Singapore	A1	401	7.6	5.2	0.61
Korea, Democratic Republic of	G6	1318	5.4	4.3	0.53
China	C4	66 466	4.9	3.8	0.43
Qatar	A3	33	1.7	3.5	0.45
Jordan	D5	129	2.0	3.2	0.37
Lebanon	D6	142	3.3	3.2	0.35
Mongolia	D5	66	2.3	3.1	0.38
Syrian Arab Republic	G6	467	2.2	3.1	0.34
State of Palestine	F6	71	1.7	3.1	0.36
Kazakhstan	G2	491	3.0	2.9	0.33
Iraq	F6	581	1.7	2.9	0.32
Georgia	G2	167	3.9	2.7	0.29
Bahrain	A3	23	1.7	2.6	0.25
Iran, Islamic Republic of	C6	1641	2.2	2.6	0.28
Malaysia	C2	611	2.1	2.4	0.28
Saudi Arabia	D6	454	1.6	2.3	0.26
United Arab Emirates	D6	64	0.8	2.3	0.29
Kyrgyzstan	G2	91	1.7	2.2	0.26
Kuwait	A2	34	1.2	2.2	0.26
Timor-Leste	G6	14	1.2	2.1	0.26
Oman	A3	36	1.2	2.1	0.25
Armenia	G3	78	2.5	1.9	0.22
Turkmenistan	G2	75	1.5	1.8	0.21
Brunei	F5	6	1.5	1.8	0.16
Indonesia	F6	3225	1.3	1.5	0.17
Philippines	B2	1008	1.0	1.4	0.16
Tajikistan	G3	63	0.9	1.4	0.16
Afghanistan	G6	237	0.7	1.3	0.16
Azerbaijan	G2	135	1.4	1.3	0.15
Pakistan	E6	1646	0.9	1.3	0.14
Uzbekistan	G2	283	1.0	1.2	0.14
Thailand	B3	1017	1.5	1.2	0.13
Myanmar	G6	476	1.0	1.1	0.12
Lao PDR	G6	52	0.8	1.1	0.12
Nepal	G6	218	0.7	1.0	0.12
India	C5	9658	0.8	0.9	0.11
Cambodia	G6	101	0.7	0.9	0.10
Viet Nam	E4	810	0.9	0.9	0.09
Sri Lanka	D6	221	1.0	0.9	0.09
Bangladesh	F6	900	0.6	0.8	0.08
Yemen	E6	112	0.4	0.6	0.07
Bhutan	D6	3	0.4	0.6	0.06

ASR = age-standardised rate.

Data are sorted by ASRs. Numbers are expressed per 100 000 people. Reproduced with permission from the International Agency for Research on Cancer [3].

For Quality legend, please refer to the Supplementary material (Level of availability of incidence and mortality data).